ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,919.80
-0.03%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Coley Pharmaceutical Grp. (MM) (COLY)

  7. Coley Pharmaceutical Grp. (MM) (COLY) Noticias

COLY

Coley Pharmaceutical Grp. (MM) (COLY)

Coley Pharmaceutical Grp. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:COLY
FechaHoraFuenteTítuloSímboloCompañía
04/01/200816:35PR Newswire (US)QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer IndexNASDAQ:COLYColey Pharmaceutical Grp. (MM)
03/01/200813:58Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
31/12/200708:11Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
31/12/200707:00Business WirePfizer Inc Announces Completion of the Tender Offer Relating to Outstanding Shares of Coley Pharmaceutical Group, Inc.NASDAQ:COLYColey Pharmaceutical Grp. (MM)
21/12/200715:13Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Statement of Beneficial Ownership (SC 13D)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
18/12/200707:00Business WirePfizer Inc Clears Antitrust Review for Acquisition of All Outstanding Shares of Coley Pharmaceutical Group, Inc.NASDAQ:COLYColey Pharmaceutical Grp. (MM)
14/12/200715:12Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Statement of Changes in Beneficial Ownership (4)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
30/11/200707:59Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
30/11/200707:55Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Tender offer statement by Third Party (SC TO-T)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
28/11/200705:04Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
26/11/200712:29PR Newswire (US)Coley Pharmaceutical Group to Present at the Lazard Capital Markets Fourth Annual Healthcare ConferenceNASDAQ:COLYColey Pharmaceutical Grp. (MM)
20/11/200715:50Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Amended Current report filing (8-K/A)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
19/11/200711:58Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Amended Statement of Ownership (SC 13G/A)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
16/11/200715:15Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Current report filing (8-K)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
16/11/200708:35Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Written communication relating to an issuer or third party (SC TO-C)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
01/11/200715:05PR Newswire (US)Coley Pharmaceutical Group Reports Third Quarter and Nine-month Financial ResultsNASDAQ:COLYColey Pharmaceutical Grp. (MM)
31/10/200713:24PR Newswire (US)Coley Pharmaceutical Group to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare ConferenceNASDAQ:COLYColey Pharmaceutical Grp. (MM)
30/10/200708:00PR Newswire (US)Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical DevelopmentNASDAQ:COLYColey Pharmaceutical Grp. (MM)
29/10/200708:00PR Newswire (US)Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus ErythematNASDAQ:COLYColey Pharmaceutical Grp. (MM)
26/10/200710:34PR Newswire (US)Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKlineNASDAQ:COLYColey Pharmaceutical Grp. (MM)
25/10/200707:30PR Newswire (US)Coley Pharmaceutical Group to Report Third Quarter Results on November 1, 2007NASDAQ:COLYColey Pharmaceutical Grp. (MM)
09/10/200707:11Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Securities Registration (section 12(b)) (8-A12B)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
08/10/200707:30PR Newswire (US)Coley Pharmaceutical Group Adopts Shareholder Rights PlanNASDAQ:COLYColey Pharmaceutical Grp. (MM)
20/09/200714:18Edgar (US Regulatory)Coley Pharmaceutical Group, Inc. (Other) (4)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
05/09/200707:30PR Newswire (US)Coley Pharmaceutical Group to Present at Bear, Stearns & Co. 20th Annual Healthcare ConferenceNASDAQ:COLYColey Pharmaceutical Grp. (MM)
02/08/200715:05PR Newswire (US)Coley Pharmaceutical Group Reports Second Quarter and Six-month Financial ResultsNASDAQ:COLYColey Pharmaceutical Grp. (MM)
31/07/200707:30PR Newswire (US)Coley Pharmaceutical Group to Present at the Canaccord Adams 27th Annual Global Growth ConferenceNASDAQ:COLYColey Pharmaceutical Grp. (MM)
25/07/200707:30PR Newswire (US)Coley Pharmaceutical Group to Report Second Quarter Results on August 2, 2007NASDAQ:COLYColey Pharmaceutical Grp. (MM)
28/06/200716:02PR Newswire (US)Coley Pharmaceutical Group Grants Dynavax License for Commercialization of HEPLISAV(TM)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
20/06/200713:57PR Newswire (US)Coley Pharmaceutical Group Announces Pfizer's Discontinuation of Clinical Trials for PF-3512676 Combined with Cytotoxic ChemotheNASDAQ:COLYColey Pharmaceutical Grp. (MM)
 Showing the most relevant articles for your search:NASDAQ:COLY

Su Consulta Reciente

AMEX
KOCG
Fis Knights of Columbus ...
BOV
U2PW34
Upwork
BIT
GS0242
Goldman Sachs
ASX
1ADN
AdAlta
LSE
ARKK
Ark Innovation
BITMOT
988017
World Bank Sustainable T...
NASDAQ
PCJRX
Putnam RetirementReady 2...
NYSE
CCCS.WS
CCC Intelligent Solutions
COIN
FODLETH
Fodl
EU
6280T
6280T
NASDAQ
PGPAJX
Peroni Growth Portfolio ...
BIT
UR9UH3
UniCredit Bank
ASX
SMSO
Star Minerals
USOTC
PRRUF
Immutep (PK)
LSE
BW67
Natixis St.31
NASDAQ
AAYVYXX
Hsbc Usa Inc Autocallabl...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados